ENGINEERING OF POTENCY-ENHANCED TCR-EDITED T CELLS FOR SHARED NEOANTIGEN-TARGETED CANCER IMMUNOTHERAPY

被引：0

作者：

Kok, Lianne ^{[1
]}

Eshuis, Sander ^{[1
]}

Kroon, Paula ^{[1
]}

Tubb, Vanessa ^{[1
]}

Kong, Xiangjun ^{[1
]}

Linnemann, Carsten ^{[1
]}

Bendle, Gavin ^{[1
]}

van Heijst, Jeroen ^{[1
]}

机构：

[1] Neogene Therapeut, Amsterdam, Netherlands

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.0239

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

239

引用

页码：A253 / A253

页数：1

共 13 条

[1] Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Zhi Pang
Man-man Lu
Yu Zhang
Yuan Gao
Jin-jin Bai
Jian-ying Gu
Lu Xie
Wei-zhong Wu
Biomarker Research, 11
[2] Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Pang, Zhi
Lu, Man-man
Zhang, Yu
Gao, Yuan
Bai, Jin-jin
Gu, Jian-ying
Xie, Lu
Wu, Wei-zhong
BIOMARKER RESEARCH, 2023, 11 (01)
[3] The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
Karpanen, Terhi
Olweus, Johanna
FRONTIERS IN IMMUNOLOGY, 2017, 8
[4] TCR gene edited memory stem T cells for cancer immunotherapy
Bonini, C.
HUMAN GENE THERAPY, 2016, 27 (11) : A15 - A15
[5] Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy
Yossef, Rami
Tran, Eric
Deniger, Drew C.
Gros, Alena
Pasetto, Anna
Parkhurst, Maria R.
Gartner, Jared J.
Prickett, Todd D.
Cafri, Gal
Robbins, Paul F.
Rosenberg, Steven A.
JCI INSIGHT, 2018, 3 (19):
[6] Treatment of ovarian cancer cells with olaparib and trabectedin modulates the expression of immune-related molecules and the killing ability of TCR-edited T cells
Bergamini, Alice
Tassi, Elena
Trippitelli, Federica
Maffia, Maria Chiara
Candiani, Massimo
Bocciolone, Luca
Candotti, Giorgio
Pavone, Giacomo
Parretta, Mariangela
Rabaiotti, Emanuela
Cioffi, Raffaella
Pella, Francesca
Galli, Federica
Potenza, Alessia
Cianciotti, Beatrice
Magnani, Zulma
Ruggiero, Eliana
Mangili, Giorgia
Bonini, Chiara
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A505 - A505
[7] Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
Ingels, Joline
De Cock, Laurenz
Stevens, Dieter
Mayer, Rupert L.
Thery, Fabien
Sanchez, Guillem Sanchez
Vermijlen, David
Weening, Karin
De Smet, Saskia
Lootens, Nele
Brusseel, Marieke
Verstraete, Tasja
Buyle, Jolien
Van Houtte, Eva
Devreker, Pam
Heyns, Kelly
De Munter, Stijn
Van Lint, Sandra
Goetgeluk, Glenn
Bonte, Sarah
Billiet, Lore
Pille, Melissa
Jansen, Hanne
Pascal, Eva
Deseins, Lucas
Vantomme, Lies
Verdonckt, Maarten
Roelandt, Ria
Eekhout, Thomas
Vandamme, Niels
Leclercq, Georges
Taghon, Tom
Kerre, Tessa
Vanommeslaeghe, Floris
Dhondt, Annemieke
Ferdinande, Liesbeth
Van Dorpe, Jo
Desender, Liesbeth
De Ryck, Frederic
Vermassen, Frank
Surmont, Veerle
Impens, Francis
Menten, Bjorn
Vermaelen, Karim
Vandekerckhove, Bart
CELL REPORTS MEDICINE, 2024, 5 (05)
[8] Non-Viral Engineering of Human iPS Cells to Manufacture Rejuvenated TCR T Cells for Cancer Immunotherapy
Osawa, M.
Akizuki, M.
Gee, P.
Ueno, M.
Saikawa, R.
Sato, E.
Koizumi, K.
Ohara, K.
Okuyama, K.
Sakamoto, S.
Yokoyama, N.
Ueda, S.
Wang, B.
Kawai, Y.
Nakatsura, T.
Hamana, H.
Kishi, H.
Kaneko, S.
Calvin, B.
Yasumichi, H.
HUMAN GENE THERAPY, 2021, 32 (19-20) : A88 - A88
[9] Enhanced detection of T-cells targeting unique neoantigens and shared mutated oncogenes for personalized cancer immunotherapy
Yossef, Rami
Tran, Eric
Gros, Alena
Deniger, Drew
Cafri, Gal
Rosenberg, Steven A.
CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
[10] Generation of off-the-shelf TCR-less CAR-targeted cytotoxic T cells from renewable pluripotent cells for cancer immunotherapy
Clarke, Raedun L.
van der Stegen, Sjoukje
Lee, Tom
Mansilla-Soto, Jorge
Chang, Chia-wei
Sasaki, Jeffrey
Husain, Mushtaq
Peralta, Eigen
Hardy, Ian
Ortiz, Edwin
Riviere, Isabelle
Sadelain, Michel
Valamehr, Bahram
CANCER RESEARCH, 2018, 78 (13)

← 1 2 →